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ABSTRACT 
Background. Depression is a risk factor for diabetes and diabetes increase the risk 
for depression. Depression contributes to progression of diabetes mellitus. 
Examination of fructosamine is used to monitor blood sugar control for 2-3 weeks 
(according to age albumin). LPD evoke the relaxation response, which expected to 
improve symptoms of stress or depression. 
Objective. To determine the decrease in fructosamine levels in the group of patients 
with diabetes mellitus with depression symptoms after administration of fluoxetine 
alone compared with a combination of fluoxetine and LPD. 
Methods. This research conducted in Dr.Soeradji Tirtonegoro General Hospital, in 
May to August 2014. Distribution of data tested using the Shapiro-Wilk test. The 
differences between fructosamine and BDI (Beck Depression Inventory) before and 
after treatment tested with a pair t-test if normally distributed or Wilcoxon test if it 
was not normally distributed. The decrease in fructosamine and BDI both groups 
compared by independent t-test if normally distributed or Mann Whitney U test if 
not normally distributed. Differences were considered significant if p <0.05 with a 
confidence interval of 95%. 
Result. There was a significant decrease in fructosamine levels in treatment group 
from 293.90±140.042 to 239.01±133.13 after treatment with p value 0.017 (p <0.05). 
Control group from 263.13±163.65 to 219.01±149.33 with p value 0.001 (p<0.05). 
The decrease of fructosamine levels not differ in the treatment group 67.24±102.71 
than the control group 71.14 ± 72.77 with p value = 0.902 (p> 0.05).  
Conclusion. LPD had no effect on fructosamine levels of type 2 diabetes mellitus 
patients with depression symptoms. 
Keywords: LPD, symptoms of depression, fructosamine, BDI (Beck Depression 
Inventory) 
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ABSTRAK  
Latar Belakang. Depresi merupakan faktor risiko terjadinya diabetes dan diabetes 
meningkatkan risiko untuk terjadinya depresi. Depresi memberikan kontribusi terhadap 
perjalanan penyakit diabetes melitus. Pemeriksaan fruktosamin digunakan untuk memantau 
kontrol kadar gula darah selama 2 – 3 minggu (sesuai usia albumin).  
LPD menimbulkan respon relaksasi yang diharapkan mampu memperbaiki gejala stres atau 
gejala depresi.  
Tujuan penelitian.  Untuk mengetahui penurunan kadar fruktosamin pada kelompok pasien 
diabetes melitus dengan gejala depresi setelah pemberian fluoxetin saja dibandingkan dengan 
kombinasi fluoxetin dan LPD. 
Metode. Penelitian ini dilakukan di RSUD Dr.Soeradji Tirtonegoro, Klaten pada bulan Mei -
Agustus 2014. Distribusi atau sebaran data diuji menggunakan uji statistik Shapiro -Wilk. 
Perbedaan fruktosamin dan BDI (Beck Depression Inventory) sebelum dan sesudah perlakuan 
diuji dengan pair t-test jika terdistribusi normal atau Wilcoxon test  jika tidak terdistribusi 
normal. Perbedaan penurunan fruktosamin dan BDI kedua kelompok dibandingkan dengan 
independent t-test jika terdistribusi normal atau Mann Whitney U test jika tidak terdistribusi 
normal.  Perbedaan dianggap bermakna bila p < 0,05 dengan interval kepercayaan 95 %.  
Hasil Penelitian. Penurunan kadar fruktosamin secara bermakna pada kelompok perlakuan 
dari 293.90±140.042 menjadi 259.02±116.08  dengan  p=0.017 juga dialami kelompok 
kontrol dengan penurunan fruktosamin dari 263.13±163.65  menjadi 219.01±149.33 dengan 
p=0.001. Penurunan kadar fruktosamin pada kelompok perlakuan 67.24±102.71 tidak lebih 
baik daripada kelompok kontrol 71.14±72.77dengan nilai p=0.902 (p>0.05).   
Kesimpulan. Penambahan LPD pada terapi fluoxetin tidak berpengaruh  pada kadar 
fruktosamin penderita diabetes melitus tipe 2 dengan simtom depresi.  
 
Kata Kunci: LPD, simtom depresi, fruktosamin, BDI (Beck Depression Inventory) 
 
 
Introduction 
Diabetes mellitus (DM) is a group 
of metabolic disorders characterized 
by chronic hyperglycemia due to 
relative or absolute insulin deficiency. 
The diagnosis of diabetes is made 
based on the criteria of American 
Diabetes Association (ADA) that is 
the fasting blood glucose levels 
≥126mg/dL, blood glucose levels 2 
hours after loading ≥ 200 mg / dL, 
HbA1c levels ≥ 6.5%, the classic 
symptoms of hyperglycemia or 
hyperglycemic crisis with random 
blood glucose levels ≥ 200 mg / dL.1  
Latihan pasrah diri is a method that 
combines relaxation and remembrance 
with a focus on breathing exercises 
and words contained in the dhikir 
(Relaxation and meditation prayer). 
Latihan pasrah diri induce the 
relaxation response, which expected to 
improve the symptoms of stress or 
depressive symptoms. These 
conditions affect directly or indirectly 
on the inflammatory response and 
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outcomes improve blood sugar 
control. Induce the relaxation 
response that expected to improve the 
symptoms of stress or depressive 
symptoms. These conditions affect 
directly or indirectly on the 
inflammatory response and outcomes 
improve blood sugar control. Latihan 
pasrah diri should be done for 21 days 
so that the body becomes accustomed 
to it.2 
Examination of fructosamine or 
glycated albumin used to indicate a 
protein that has been glycated with 
glucose (the bond between glucose 
and albumin) via a non-enzymatic 
reaction. In general, the fructosamine 
value correlates well with HbA1c. 
Examination of fructosamine used to 
monitor blood sugar control for 2-3 
weeks (according to age albumin). 
Examination of fructosamine 
particularly useful in the condition of 
pregnancy or the hemoglobin 
disorders.3 
Depression is a risk factor for 
diabetes and diabetes increase the risk 
for depression. Depression 
contributes to the disease course of 
diabetes mellitus in terms of reduced 
adherence to treatment and diet, 
reduced physical activity, reduced 
glycemic control, reduces quality of 
life, cause disability, and rising health 
care costs.4 SSRIs such as fluoxetine, 
fluvoxamin, paroxetin, sertraline, and 
citalopram are the result of studies to 
obtain drugs as effective as tricyclic 
antidepressants with better security.5 
 
 
Research Methods 
This study is a retrospective cohort 
clinical trial to determine the effect of 
fluoxetine compared to fluoxetine and 
exercise resigned themselves to the 
fructosamine levels in patients type 2 
diabetes mellitus with symptoms of 
depression, by taking secondary data. 
The study conducted at the clinic of 
Internal Medicine RSUD Dr. Soeradji 
Tirtonegoro, Klaten. When the study 
in May 2014 until August 2014. 
Patients were included in this study 
were patients with type 2 diabetes who 
underwent routine therapy in the 
clinic accompanied by symptoms of 
depression, and are willing to 
participate in the study by signing a 
letter of consent (informed consent), 
aged less than 65 years. Patients were 
excluded if they meet the inclusion 
criteria like the antidepressant drug 
therapy, psychotherapy, infections, 
rheumatoid arthritis disease history, 
creatinine levels> 3 mg/dL, and 
patients who cannot read or write, or 
suffering from heart failure. 
The data presented in the form of 
mean and standard deviations. To 
measure the distribution of the data 
used statistical tests Shapiro Wilk. 
Differences fructosamine and BDI 
(Beck Depression Inventory) before 
and after treatment tested with the 
pair t-test if normally distributed or 
Wilcoxon test if it is not normally 
distributed. Differences decrease in 
fructosamine and BDI both groups 
compared by independent t-test if 
normally distributed or Mann Whitney 
U test if not normally distributed. 
Acta Interna The Journal of Internal Medicine, Volume 7 No. 1 June 2017:29-37 
 
 
 
Differences were considered 
significant if p <0.05 with a 
confidence interval of 95%. 
 
Result 
The study conducted over three 
months at RSUD Klaten. 257 people 
with type 2 diabetes do charging BDI 
questionnaire to seek the presence or 
absence of symptoms of depression. 
79 people with type 2 diabetes who 
had symptoms of depression. 38 
people who met the inclusion and 
exclusion criteria were divided into 2 
groups of randomized trials. 
The treatment group Latihan 
Pasrah Diri (LPD) consisting of 19 
people and a control group that did 
not get special treatment 19 people. 
There are three people in the 
treatment group who did not continue 
research, and 3 people in the control 
group who did not continue the study, 
so the LPD group and the control 
group each attended by 16 people. 
 
Fluoxetine treatment group 
therapy plus LPD 
The group was getting a 
workout technique LPD with 
subsections psychosomatic 
supervision by staff, and then 
performs LPD 2 times daily for 21 
days (3 weeks) in a row. The control 
group did not receive special 
treatment, just a plain relaxation. The 
evaluations of the results toke after 
treatment in the form of fructosamine 
levels and BDI score. 
 
Table 1 Baseline characteristic  
Characteristic LPD Group Control Group P value 
Gender 
Male 
Female 
Age (years) 
Blood Pressure 
Systolic 
Diastolic 
BDI score  
Before treatment 
Fructosamine 
Before treatment 
 
 
6 (37.5%) 
10 (62.5%) 
52.38 ± 4.23 
 
128.75 ± 15.86 
86.87±135 
 
18.31 ± 10.05 
 
293.90 ± 140.04 
 
4 (25%) 
12 (75%) 
54.38 ± 5.63 
 
134.38 ± 18.25 
86.87±135 
 
17.75 ± 15.46 
 
263.13 ± 163.86 
 
p=0.453 
 
p=0.266 
 
p=0.377 
p=0.984* 
 
p=0.488 
 
p=0.572 
Description: LPD=latihan pasrah diri; statistical test by unpaired t-test,*= statistical test by Mann-
Whitney U test. 
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Table 2 Mean fructosamine levels of the treatment group and the control group before and 
after treatment. 
Group Fructosamine 
Before Treatment 
Mean±SD 
Fructosamine After 
Treatment 
Mean±SD 
P value 
LPD Group 
Control Group 
293.90±140.042 
263.13±163.65 
259.02±116.08 
219.01±149.33 
p=0.017 
p=0.001 
Description: LPD=latihan pasrah diri; statistical test by paired t-test 
 
 
Table 3 The mean score BDI treatment group and the control group before and after 
treatment. 
 
Group 
Nilai BDI 
Before treatment 
BDI Score 
After treatment 
P score 
Mean±SD Min-Max Mean±SD Min-Max  
LPD Group 
Control Group 
18.31±10.05 
17.75±15.46 
 
 
2-61 
 
16.50±12.69 
14.62±12.5 
 
 
2-41 
p=0.041 
p=0.001* 
Description : LPD=latihan pasrah diri; statistical test by paired t test, * = statistical test by Wilcoxon 
test 
 
 
Table 4 The mean BDI and fructosamine impairment treatment group and the control 
group after treatment. 
Impairment BDI 
score and 
Fructosamine 
LPD Group 
 
Control Group  p value 
 
 Mean±SD Min-Max Mean±SD Min-Max 
Impairment BDI 
score 
(∆ BDI score) 
Impairment 
Fruktosamin 
(∆Fruktosamin) 
7.94±3.18 
 
 
67.24±102.71 
1-25 6.12±6.33 
 
 
71.14±72.77 
0-20 p=0.437* 
 
 
p=0.902 
Description: LPD=latihan pasrah diri; statistical test by unpaired t-test, *= statistical test by Mann-
Whitney U test. 
 
Fructosamine levels and the 
BDI score showed a normal 
distribution so the analysis by paired t-
test before and after treatment. 
Fructosamine levels decrease 
significantly in the treatment group 
from 293.90±140.042 to 
259.02±116.08 with p-value = 0.017 
also in the control group from 
263.13±163.65 to 219.01±149.33 with 
p value = 0.001. Decreased levels of 
fructosamine in the treatment group 
was no better than the control group, 
with p value = 0.902 (p> 0.05). BDI 
scores decrease significantly in the 
treatment group from 18.31±10.05 to 
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16.50±12.69 with p value= 0.041and 
also in control group also decrease 
from 17.75±15.46 to 14.62±12.5 with 
p value = 0.001. Impairment of BDI 
in the treatment group and the control 
group was not normally distributed so 
tested by Mann Whitney U test with a 
result that no significant difference 
with p value = 0.437 (p> 0.05). The 
result was not reported any complaints 
of side effects of drugs. 
 
Discussion 
This study conducted to 
determine the effects of Latihan Pasrah 
Diri (LPD) to decrease the levels of 
fructosamine in patients with type 2 
diabetes mellitus with symptoms of 
depression that treated with fluoxetine 
at RSUD Klaten. There are 257 
patients with type 2 diabetes and 
inspection score BDI (Beck 
Depression Inventory) and we find 79 
people (30.1%) with a score ≥ 10 or 
with symptoms of depression. This 
result is similar to that reported by 
Anderson et al., 2001 that found 
symptoms of depression by 31% in 
patients with type 2 diabetes who 
control routine and higher than 
reported by Roy and Lloyd in 2012 
amounted to 19.1%. BDI with a cut-
off score ≥ 10 had a sensitivity of 
84.6% and a specificity of 86.4%.6 
The treatment group who received 
LPD consisted of six men (37.5%) 
and ten women (62.5%), whereas in 
the control group consisted of 4 men 
(25%) and 12 women (75%). Statistical 
test in both groups showed no 
significant difference (p = 0453). This 
means sex differences between the 
treatment group and the control group 
is not a confounding factor. Age in in 
the treatment group (52.38 ± 4.23) 
years and the control group (54.38 ± 
5.63) years. Statistical test of mean age 
in the treatment group and control 
groups did not differ significantly (p = 
0.266). The mean systolic blood 
pressure in the treatment group 
(128.75 ± 15.86) mmHg, and the 
control group (134.38 ± 18. 25) 
mmHg (p = 377). 
 Mean diastolic blood pressure in the 
treatment group (85.29 ± 6:29) 
mmHg, and the control group (86.87 
± 13.5) mmHg (p = 0.984). BDI 
before the carrying score in the 
treatment group (18.31 ± 10.05) and 
control group (17.75 ± 15.46) (p = 
0.488). Fructosamine levels before 
treatment group (293.90 ± 140.04) 
and the control group (263.13 ± 
163.86) (p = 0572). These data 
showed that the treatment group and 
the control group had baseline data 
were not significantly different. 
Fructosamine levels decrease 
significantly in the treatment group 
from 293.90±140.042 to 
259.02±116.08 with p value= 0.017 
also in the control group from 
263.13±163.65 to 219.01±149.33 with 
p value = 0.001. BDI scores decrease 
significantly in the treatment group 
from 18.31±10.05 to 16.50±12.69 
with p value= 0.041and also in control 
group also decrease from 17.75±15.46 
to 14.62±12.5 with p value = 0.001. It 
is equal with that reported by Lustman 
et al. 2000, which showed an 
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improvement in the value of BDI 
significantly after treatment with 
fluoxetine for 8 months, but blood 
sugar levels are not significantly 
affected. 
Decreased levels of fructosamine in 
the treatment group 67.24±102.71 not 
better than the control group 71.14 ± 
72.77 with p value = 0.902 (p> 0.05). 
Decreased levels of fructosamine in 
both groups, but the addition of 
latihan pasrah diri themselves to the 
treatment group did not provide an 
improvement in the decrease of 
fructosamine. Impairment of BDI in 
the treatment group and the control 
group was not normally distributed so 
as tested by Mann Whitney U test with 
a result that no significant difference 
with p = 0437. McGinnis et al., 2005 
showed that the relaxation for 3 
months could lower the value of BDI, 
blood pressure and A1C. McGinnis 
researches unfinished in combination 
with fluoxetine administration. So our 
results may affect by the 
administration of fluoxetine as a 
standard therapy for depression. 
Fructosamine complaints from the use 
of fluoxetine and practice surrender. 
 
 
Conclusion 
Latihan Pasrah Diri (LPD) as non-drug 
intervention therapeutic does not 
significant affect the decrease in 
fructosamine levels in patients with 
type 2 diabetes mellitus with 
symptoms of depression who gained 
fluoxetine therapy. Further research is 
needed to compare the effect of LPD 
and fluoxetin to frukosamin level in 
patients with type 2 diabetes mellitus  
 
 
 
with symptoms of depression. 
Necessary to check the levels of 
albumin, new stressors, monitoring 
medicines consumed by patients in the 
form of continuity of treatment during 
the study,  recording the rest of the 
drug and supervisors to take 
medication, and most importantly, a 
strict monitoring in doing LPD and 
relaxation with a decrease in pulse 2-4 
beats / min. 
References 
1. American Diabetes Association. 
2013. Diagnosis and Classification 
of Diabetes Mellitus. Diabetes 
Care. Vol 36 Supplement 1, S67.  
2. Asdie A.H. 2000. Patogenesis dan 
Terapi Diabetes Melitus Tipe 2.  
3. Medika.  Fakultas Kedokteran 
Universitas Gadjah Mada, 
Yogyakarta.  
4. Khan H.A., Sobki S.H., Alhomida 
A.S., Khan S.A. 2007. Paired 
Values of Serum Fructosamine and 
Blood Glucose for the Screening of 
Gestational Diabetes Mellitus. 
Indian Jo of Clinical Biochemistry; 
22 (1) 65-70. 
5. Bogner H.R., Morales K.H., de 
Vries H.F., Cappola A.R. 2012. 
Integrated Management of Type 2 
Diabetes Melitus and Depression 
Treatment to Improve Medication 
Adherence: A Randomized 
Acta Interna The Journal of Internal Medicine, Volume 7 No. 1 June 2017:29-37 
 
 
Controlled Trial.Ann Fam 
Med;10:15-22.  
6. Cuevas C.D. & Sanz E.J. 2006. 
Safety of Selective Serotonin 
Reuptake Inhibitors in Pregnancy. 
Curr Drug Safety:1;17-24.  
7. McDowell I. dan Newell C. 1996. 
Measuring Health: A Guide to 
Rating Scales and Questionnaires 
2nd ed. New York: Oxford 
University Press. 
8. Anderson JR, Freedland KE, 
Clause RE, Lustman PJ. 2001. The 
Prevalence of Comorbid 
Depression in Adults with 
Diabetes. Diabetes Care. vol. 24 
no. 6 1069-1078 
9. Roy T., dan Lloyd C.E. 2012. 
Epidemiology of depression and 
diabetes: A systematic review. 
Journal of affective disorder. 
Supplement, Pages S8–S21
 
